Gallifen 200 mg/ml suspension for use in drinking water for chickens and pheasants
Gallifen 200 mg/ml suspension for use in drinking water for chickens and pheasants
Authorised
- Fenbendazole
Product identification
Medicine name:
Gallifen 200 mg/ml suspension for use in drinking water for chickens and pheasants
Active substance:
- Fenbendazole
Target species:
-
Chicken
-
Pheasant
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Fenbendazole200.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for use in drinking water
Withdrawal period by route of administration:
-
In drinking water use
-
Chicken
-
Eggs0day
-
Meat and offal8day* when used at 3 mg fenbendazole / kg bw / day
-
Meat and offal6day
-
-
Pheasant
-
Eggs0day
-
Meat and offal6dayDo not release pheasants for hunting for at least 6 days after the end of medication.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC13
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- White rectangular HDPE bottle of 1 litre with vertically see-through bar with an LDPE insert closed with white PP tamper- evident screw cap with a LDPE sealing disk.
- White HDPE canisters with white HDPE ribbed tamper-evident screw cap of 5 litres.
- White HDPE canisters with white HDPE ribbed tamper-evident screw cap of 2.5 litres.
- White cylindrical High Density Polyethylene (HDPE) bottle with white polypropylene (PP) screw tamper-evident closure of 1 litre.
- White cylindrical High Density Polyethylene (HDPE) bottle with white polypropylene (PP) screw tamper-evident closure of 125 ml.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet AD
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0579/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
